Bond.az White LogoBond.az Black Logo

CrowdStrike target raised to $621 by BTIG | Bond.az

BTIG raises CrowdStrike stock price target to $621, citing platform growth and partner feedback. Stock up 20% YTD.

Daniel Rodriguez
ByDaniel Rodriguez- Senior Editor
|
0

BTIG analyst Gray Powell raised the price target on CrowdStrike Holdings to $621 from $499, maintaining a Buy rating.

The stock currently trades at $562.57, near its 52-week high of $568.37, with shares up 11% over the past week and 20% year-to-date.

The firm conducted discussions with 10 contacts over recent weeks, including six partners and four industry analysts. The partners represent approximately $700 million in annual CrowdStrike sales on a combined basis.

Two of the six partners increased their growth expectations compared to BTIG's January quarter research. The platform consolidation story is increasingly resonating with buyers.

Positive feedback on Next-Gen SIEM was notable, while commentary on Identity, Cloud Security, VM, and newer AI Security products was encouraging. The only mixed feedback concerned seat count pressure in core endpoint security.

BTIG said the headwind from endpoint security is more than offset by accelerating adoption of the broader platform.

In other recent news, CrowdStrike launched Jet, a mobile app for partners, added eight partners to Project QuiltWorks, and introduced Falcon OverWatch for Defender. Mizuho upgraded the stock to Outperform.

More News
2026-06-01 12:02
|
743

Legend Biotech Buy Rating Reiterated

H.C. Wainwright reiterated its Buy rating for Legend Biotech with a $50 target. Revenue up 56% over twelve months.

0
2026-06-01 12:01
|
475

Cogent Stock Price Target Raised to $55

Cogent Biosciences PEAK trial: combination therapy shows 45.6% response rate, 16.5 months PFS, FDA accepts NDA. H.C. Wainwright raises price target to $55.

0
2026-06-01 12:00
|
841

H.C. Wainwright Reaffirms Mineralys Buy

H.C. Wainwright reiterated a Buy rating on Mineralys Therapeutics with a $56 price target after positive trial data.

0
2026-06-01 10:33
|
714

Goldman Sachs Upgrades Marriott Vacations Stock

Goldman Sachs upgrades Marriott Vacations stock to Buy, price target $100. Execution potential drives earnings upside.

0
2026-06-01 10:32
|
730

Goldman Sachs Upgrades Travel + Leisure Stock to Buy

Goldman Sachs upgraded Travel + Leisure stock to Buy with a $85 price target. Learn about the company's financials, dividends, and market outlook.

0
2026-06-01 10:32
|
238

Canaccord Initiates Rare Earths Americas with Buy

Canaccord Genuity initiates Rare Earths Americas with a buy rating and $25 target. Stock at $21.85, offering 14% upside potential.

0
2026-06-01 10:30
|
651

BofA Raises Icon Stock Target to $125 on Bookings

BofA Securities raised Icon plc price target to $125, maintains Underperform. Improved booking trends and Q4 results drive revision.

0
2026-06-01 10:03
|
748

RBC Capital: Sprouts faces Kroger risk

RBC Capital keeps Sprouts rating but sees risks from Kroger price cuts. Analysis and outlook on Bond.az.

0
2026-06-01 09:02
|
551

CLSA Rates Chagee Hold on Margins

CLSA initiated Chagee Holdings with Hold rating and $10 target. Bond.az analysis reveals stock may be undervalued. Read more.

0
2026-06-01 08:31
|
594

Barclays Downgrades Sensata Stock on Valuation

Barclays downgrades Sensata stock to Equalweight on valuation concerns, but raises price target to $53. Stock surged 92% in past year.

0
2026-06-01 08:05
|
946

UBS Initiates Veritone Coverage with Neutral

UBS initiated coverage on Veritone with a Neutral rating and $2.50 price target. The AI company is better positioned for growth after transformation.

0
2026-06-01 08:02
|
892

JMP Securities Initiates Microsoft with Outperform on AI Strategy

JMP Securities initiates Microsoft with Market Outperform rating and $550 target on AI strategy. Revenue growth expected to reach 17% in FY2026.

0
...
CrowdStrike target raised to $621 by BTIG | Bond.az | Bond.az